<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>National Heart and Lung Institute</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/7F033DCF-01A9-4B90-BA84-B74B856C5CD2"><gtr:id>7F033DCF-01A9-4B90-BA84-B74B856C5CD2</gtr:id><gtr:firstName>Cecilia</gtr:firstName><gtr:surname>Johansson</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0800311"><gtr:id>F279D0F5-E3AC-4F29-A254-324E2021B75E</gtr:id><gtr:title>Regulation of interferon production in the lung during respiratory syncytial virus infection</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0800311</gtr:grantReference><gtr:abstractText>All children are infected with respiratory syncytial virus (RSV) before age of two and most of the time the infection gives symptoms of a normal cold. However, in 2-3% of infants RSV infection lead to severe disease, called bronchiolitis, and to hospitalisation. Bronchiolitis is inflammation of the lower parts of the lungs, the bronchioles. During RSV infection the immune system has to combat the virus but also make sure that the lungs are not damaged and this appears to fail in the small % of infants who develop bronchiolitis. Therefore, it is important to understand how the immune responses are induced and regulated during RSV infection. This research proposal will focus on how the immune system senses the presence of RSV in the lungs and how this lead to production of early mediators, called interferons, which have been implicated both in resistance to the virus and in prevention of bronchiolitis. The results from this proposal may therefore impact on strategies for finding efficient immune therapies for bronchiolitis or for developing vaccines against RSV.</gtr:abstractText><gtr:technicalSummary>Respiratory syncytial virus (RSV) is a common cause of respiratory tract infections in humans. In 2-3% of children the infection leads to severe bronchiolitis such that RSV is by far the most common cause of hospitalisation among infants. Severe bronchiolitis is associated with polymorphisms in several innate immune response genes, in particular many that control the IFN system. Innate IFNs (type I and III) are produced very early and upon direct recognition of the virus. They are important for inducing antiviral responses and to activate cells of the innate and adaptive immune systems. The role of these cytokines in regulating host resistance and immunopathology during RSV infection in young and adults is poorly understood. 
Using a mouse model of RSV disease I will study the molecular and cellular regulation of innate IFN production in response to RSV in vivo. Firstly, I will elucidate which cells are infected by RSV and which cells produce IFNs in response to RSV in vivo. In addition, I will determine which pattern recognition receptors are involved in the induction of innate IFN production. Secondly, I will test the hypothesis that the production of innate IFNs might be limited in the young and that this contributes to the development of immunopathology (bronchiolitis). Neonatal and adult mice lacking individual IFN receptors will be infected with RSV and development of immunopathology will be compared. This will test the prediction that neonates are more dependent on signalling via each of the IFN receptors than adults because of lower overall IFN production. The results from this proposal will increase our understanding of the role of IFNs in immune responses to RSV and in the development of immunopathology during RSV infection. This will assist the development of strategies to find an efficient immune therapy to prevent RSV-associated bronchiolitis and to develop vaccines against RSV.</gtr:technicalSummary><gtr:fund><gtr:end>2015-07-12</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-07-13</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1086820</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Faculty of Medicine</gtr:department><gtr:description>Centre for Respiratory Infections</gtr:description><gtr:id>30C8E898-BC7B-4471-8E53-6FD1C88A5E85</gtr:id><gtr:impact>Several poster presentations of data from my group have been presented and discussed on the Centre symposia.</gtr:impact><gtr:outcomeId>P9zccsxiJGL-1</gtr:outcomeId><gtr:partnerContribution>Money for infrastructure have been provided by the Centre. Also Centre symposia has been organised where all scientist can present and interact.</gtr:partnerContribution><gtr:piContribution>Member of this Centre. Responsible for the seminar series run by the Centre</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Imperial CREST academy</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>B8280404-6716-4281-BEA4-5E110FEF59D9</gtr:id><gtr:impact>Co-organising the Imperial CREST Academy at Imperial College London where Imperial College is providing mentors for extracurricular science projects for 16 year old students. Postdoctoral students from Imperial College is mentoring groups of 2-5 students from local secondary schools for them to complete CREST awards. Several students groups have completed and been awarded their awards.</gtr:impact><gtr:outcomeId>56b9d0c8eb7f36.45825074</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2014,2015,2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>B3E3495E-B1D5-48AD-888E-EEEDC69A688F</gtr:id><gtr:title>Type I Interferons as Regulators of Lung Inflammation.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e8465fd0f3b36f31e109cccdfd9fa704"><gtr:id>e8465fd0f3b36f31e109cccdfd9fa704</gtr:id><gtr:otherNames>Makris S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>5a2fb0e3ace708.07051536</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59FEFB1F-43A8-406A-AEFB-B99811ADED9E</gtr:id><gtr:title>Alpha/beta interferon receptor signaling amplifies early proinflammatory cytokine production in the lung during respiratory syncytial virus infection.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a5fe711f35c219147fd6c54c608f189"><gtr:id>5a5fe711f35c219147fd6c54c608f189</gtr:id><gtr:otherNames>Goritzka M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>5459f49a27f7d5.21544589</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B3BA521E-98EF-4B32-ACA3-89424513D2BE</gtr:id><gtr:title>Neonatal antibody responses are attenuated by interferon-? produced by NK and T cells during RSV infection.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/340b918fdc6c0b9b335905e583351264"><gtr:id>340b918fdc6c0b9b335905e583351264</gtr:id><gtr:otherNames>Tregoning JS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_15226_26_23509276</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90705E6A-B93A-45CB-84C6-50932D036EB6</gtr:id><gtr:title>Alveolar macrophage-derived type I interferons orchestrate innate immunity to RSV through recruitment of antiviral monocytes.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a5fe711f35c219147fd6c54c608f189"><gtr:id>5a5fe711f35c219147fd6c54c608f189</gtr:id><gtr:otherNames>Goritzka M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>55d46c46f07540.43895398</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47EA8827-3C09-4E76-9062-6BDD9BB07E25</gtr:id><gtr:title>CD25+ natural regulatory T cells are critical in limiting innate and adaptive immunity and resolving disease following respiratory syncytial virus infection.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe12a1cd456146721212c38919a15948"><gtr:id>fe12a1cd456146721212c38919a15948</gtr:id><gtr:otherNames>Lee DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>H8TWKvzp2p8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C97578C1-4F2B-49AB-AEFA-CEC4C3AD9058</gtr:id><gtr:title>Protective and Harmful Immunity to RSV Infection.</gtr:title><gtr:parentPublicationTitle>Annual review of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fba90e472cb39c17c5b6bac5bcdf10dc"><gtr:id>fba90e472cb39c17c5b6bac5bcdf10dc</gtr:id><gtr:otherNames>Openshaw PJM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0732-0582</gtr:issn><gtr:outcomeId>58b1f4f70c4e62.57951214</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B8F5850B-4454-4ACE-8CCB-DF457B42284A</gtr:id><gtr:title>Defective immunoregulation in RSV vaccine-augmented viral lung disease restored by selective chemoattraction of regulatory T cells.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/257f19e93575ae4a797aea2abe7ee46f"><gtr:id>257f19e93575ae4a797aea2abe7ee46f</gtr:id><gtr:otherNames>Loebbermann J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_15226_26_23382205</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FFB0D43E-99ED-4434-AAE7-6E9A0950EF51</gtr:id><gtr:title>DNGR-1 is dispensable for CD8+ T-cell priming during respiratory syncytial virus infection.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b930be67abd964b8f9678855062c8303"><gtr:id>b930be67abd964b8f9678855062c8303</gtr:id><gtr:otherNames>Durant LR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>5459f41d6bc7d1.78684493</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E408D846-324B-4FF3-B78A-DB541D00F191</gtr:id><gtr:title>Type I interferon is required for T helper (Th) 2 induction by dendritic cells.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4605097239638d5f9ebc7e490f0161fb"><gtr:id>4605097239638d5f9ebc7e490f0161fb</gtr:id><gtr:otherNames>Webb LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>5a2fd8995c68e7.23785028</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ABDA3DCE-9729-475F-9A73-B8F6F6E65EA9</gtr:id><gtr:title>Regulatory T cells expressing granzyme B play a critical role in controlling lung inflammation during acute viral infection.</gtr:title><gtr:parentPublicationTitle>Mucosal immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/257f19e93575ae4a797aea2abe7ee46f"><gtr:id>257f19e93575ae4a797aea2abe7ee46f</gtr:id><gtr:otherNames>Loebbermann J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1933-0219</gtr:issn><gtr:outcomeId>pm_15226_26_22236998</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A8F8099-889C-4CB9-81E9-BAC47FCE888C</gtr:id><gtr:title>IL-10 regulates viral lung immunopathology during acute respiratory syncytial virus infection in mice.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/257f19e93575ae4a797aea2abe7ee46f"><gtr:id>257f19e93575ae4a797aea2abe7ee46f</gtr:id><gtr:otherNames>Loebbermann J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_15226_26_22393401</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D5CB364D-17A8-44F4-8C05-9C9080B2F5F7</gtr:id><gtr:title>T cell responses are elicited against Respiratory Syncytial Virus in the absence of signalling through TLRs, RLRs and IL-1R/IL-18R.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a5fe711f35c219147fd6c54c608f189"><gtr:id>5a5fe711f35c219147fd6c54c608f189</gtr:id><gtr:otherNames>Goritzka M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>56b4b584548be2.81402006</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>290E45E0-4A17-478A-AF51-A3BC600B97AD</gtr:id><gtr:title>Alveolar Macrophages Can Control Respiratory Syncytial Virus Infection in the Absence of Type I Interferons.</gtr:title><gtr:parentPublicationTitle>Journal of innate immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e8465fd0f3b36f31e109cccdfd9fa704"><gtr:id>e8465fd0f3b36f31e109cccdfd9fa704</gtr:id><gtr:otherNames>Makris S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1662-811X</gtr:issn><gtr:outcomeId>585d673f8cf595.63712020</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15D1B0C9-2AF5-45DE-B3D1-A169D616DF41</gtr:id><gtr:title>Regulatory T cells prevent Th2 immune responses and pulmonary eosinophilia during respiratory syncytial virus infection in mice.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b930be67abd964b8f9678855062c8303"><gtr:id>b930be67abd964b8f9678855062c8303</gtr:id><gtr:otherNames>Durant LR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>doi_15226_I_01295_13</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>76E07750-AB11-4711-8FE0-7FA2E6A69E6E</gtr:id><gtr:title>Respiratory syncytial virus infection: an innate perspective.</gtr:title><gtr:parentPublicationTitle>F1000Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7bee931d752a276728f5b7a8b416a9c9"><gtr:id>7bee931d752a276728f5b7a8b416a9c9</gtr:id><gtr:otherNames>Johansson C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2046-1402</gtr:issn><gtr:outcomeId>58ae0316eb0a15.28736395</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0800311</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>E3CED108-9B11-45C4-A81B-3730D641CA68</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Respiratory</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>